Resources (1-5 of 5)

1. Model Validation Document for "A Meta-Analysis of Carbon Nanotube Pulmonary Toxicity Studies – How Physical Dimensions and Impurities Affect the Toxicity of Carbon Nanotubes"

   19 Nov 2012 | | Contributor(s):: Jeremy M Gernand, Elizabeth Casman

   This document contains model learning statistics, and structure of the models utilized in the paper “A meta-analysis of carbon nanotube pulmonary toxicity studies – How physical dimensions and impurities affect the toxicity of carbon nanotubes.” This information is meant to supplement and support...

2. BME 695L Lecture 13: Designing Nanomedical Systems (NMS) for In-vivo Use

   22 Nov 2011 | | Contributor(s):: James Leary

   See references below for related reading.13.1      Bringing in-vivo considerations into NMS design13.1.1    the in-vitro to ex-vivo to in-vivo paradigm         13.1.1.1 In-vitro - importance of choosing...

3. BME 695L Lecture 14: Designing and Testing Integrated Nanomedical Systems

   22 Nov 2011 | | Contributor(s):: James Leary

   See references below for related reading.14.1      Introduction to integrated designs14.1.1    “Total design” but there is some order in the design process14.1.2    A brief outline of the total design...

4. BME 695L Lecture 3: Theranostics and Molecular Imaging

   07 Sep 2011 | | Contributor(s):: James Leary

   See references below for related reading.3.1      Nanomedical systems – levels of challenges3.1.1    Diagnosis - difficult3.1.2    Therapy – more difficult3.1.3    Both ("Theragnosis") – most...

5. BME 695N Lecture 18: Designing nanodelivery systems for in-vivo use

   out of 5 stars 

   12 Nov 2007 | | Contributor(s):: James Leary

   Outline:Overview – the in-vitro to ex-vivo to in-vivo paradigm In-vitro - importance of choosing suitable cell lines Ex-vivo – adding the complexity of in-vivo background while keeping the simplicity of in-vitro In-vivo - all the complexity of ex-vivo plus the “active” components of a real...